We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+8.87%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$34.2B
AUM Growth
+$2.41B
(+7.6%)
Cap. Flow
-$59.6M
Cap. Flow
% of AUM
-0.17%
Top 10 Holdings %
Top 10 Hldgs %
26.19%
Holding
2,465
New
206
Increased
1,202
Reduced
956
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$31.6M |
| 2 |
PetMed Express
PETS
|
+$29.7M |
| 3 |
Albemarle
ALB
|
+$27.7M |
| 4 |
Walmart Inc
WMT
|
+$27.2M |
| 5 |
NextEra Energy
NEE
|
+$27M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$155M |
| 2 |
Apple
AAPL
|
+$97M |
| 3 |
Microsoft
MSFT
|
+$75.4M |
| 4 |
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
|
+$60.1M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$39.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.69% |
| 2 | Consumer Discretionary | 14.5% |
| 3 | Communication Services | 10.43% |
| 4 | Healthcare | 10.27% |
| 5 | Financials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VBIV
2201
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $162K | ﹤0.01% |
1,610
+5
| +0.3% | +$487 |
|
|
PAE
2202
DELISTED
PAE Incorporated Class A Common Stock
PAE
| $160K | ﹤0.01% |
18,014
+2,229
| +14% | +$19.2K |
|
2203
Arlo Technologies
ARLO
$1.4B
| $158K | ﹤0.01% |
23,332
-209
| -0.9% | -$1.36K |
|
2204
Comstock Resources
CRK
$3.97B
| $158K | ﹤0.01% |
+23,760
| New | +$137K |
|
2205
Liberty Latin America Class A
LILA
$1.51B
| $158K | ﹤0.01% |
16,791
-1,767
| -10% | -$16.8K |
|
2206
VistaGen Therapeutics
VTGN
$9.29M
| $156K | ﹤0.01% |
+1,654
| New | +$123K |
|
|
AKUS
2207
DELISTED
Akouos Inc
AKUS
| $156K | ﹤0.01% |
12,417
+1,131
| +10% | +$15.3K |
|
|
FSP
2208
Franklin Street Properties
FSP
$44.8M
| $155K | ﹤0.01% |
29,400
-1,164
| -4% | -$6.25K |
|
2209
Neurogene
NGNE
$696M
| $155K | ﹤0.01% |
837
+116
| +16% | +$25.7K |
|
|
BTRS
2210
DELISTED
BTRS Holdings Inc. Class 1 Common Stock
BTRS
| $155K | ﹤0.01% |
+12,300
| New | +$178K |
|
2211
Q32 Bio
QTTB
$450M
| $154K | ﹤0.01% |
1,174
+321
| +38% | +$40.1K |
|
2212
PG&E
PCG
$47.8B
| $153K | ﹤0.01% |
15,051
+1,271
| +9% | +$13.6K |
|
|
CMRX
2213
DELISTED
Chimerix, Inc.
CMRX
| $152K | ﹤0.01% |
18,939
+3,038
| +19% | +$25.3K |
|
2214
Altimmune
ALT
$539M
| $151K | ﹤0.01% |
+15,320
| New | +$209K |
|
2215
Black Diamond Therapeutics
BDTX
$101M
| $151K | ﹤0.01% |
12,406
+2,577
| +26% | +$50.9K |
|
|
TECX
2216
Tectonic Therapeutic
TECX
$573M
| $150K | ﹤0.01% |
1,410
+137
| +11% | +$16.2K |
|
|
BCOV
2217
DELISTED
Brightcove, Inc.
BCOV
| $150K | ﹤0.01% |
10,432
-111
| -1% | -$1.78K |
|
|
BDSI
2218
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $150K | ﹤0.01% |
41,869
+3,900
| +10% | +$13.8K |
|
|
TPC
2219
Tutor Perini Cor
TPC
$4.57B
| $148K | ﹤0.01% |
10,705
-214
| -2% | -$3.41K |
|
|
HARP
2220
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $148K | ﹤0.01% |
+1,070
| New | +$204K |
|
|
CTT
2221
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $148K | ﹤0.01% |
12,690
-336
| -3% | -$3.9K |
|
2222
Uranium Energy
UEC
$4.71B
| $146K | ﹤0.01% |
55,064
+2,569
| +5% | +$7.74K |
|
|
CPRX
2223
DELISTED
Catalyst Pharmaceutical
CPRX
| $145K | ﹤0.01% |
25,190
-743
| -3% | -$3.83K |
|
2224
Peabody Energy
BTU
$2.78B
| $144K | ﹤0.01% |
18,144
+1,215
| +7% | +$7.19K |
|
2225
Korro Bio
KRRO
$153M
| $144K | ﹤0.01% |
289
+61
| +27% | +$29.8K |
|
Similar funds
ProShare Advisors's Q2 2021 Portfolio in Review
As of Q2 2021, ProShare Advisors held 2,465 positions worth $34.2B, up 7.6% from $31.8B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
ProShare Advisors's Q2 2021 filing shows 206 new, 1,202 increased, 956 reduced and 98 closed positions. Its largest new stake was Trinity Industries: 371,743 shares worth $10M. The largest sale was Amazon, an estimated $155M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- ProShare Advisors's largest Q2 2021 buy was Trinity Industries: 371,743 shares worth $10M.
- ProShare Advisors added most to Johnson & Johnson in Q2 2021, an estimated $31.6M increase.
- ProShare Advisors's biggest Q2 2021 reduction was Amazon, cutting an estimated $155M.
- ProShare Advisors fully exited Just Eat Takeaway.com N.V. American Depositary Shares in Q2 2021, selling an estimated $60.1M.
- ProShare Advisors's ten largest holdings make up 26% of its $34.2B portfolio in Q2 2021.
- ProShare Advisors opened 206 new positions and closed 98 in Q2 2021.
- ProShare Advisors's portfolio value rose 7.6% quarter-over-quarter to $34.2B.
Based on ProShare Advisors's 13F filing for Q2 2021, filed 13 Aug 2021.